Cancer pattern among hypertensive patients in North Karelia, Finland

Journal of Human Hypertension

Volumn 19, Issue 5, 2005, Pages 373-379

  Lindgren, A M ^a   Nissinen, A M ^a,b,c   Tuomilehto, J O ^b,d,e   Pukkala, E ^f  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

^f FINNISH CANCER REGISTRY   (Finland)

Author keywords

Antihypertensive drugs; Blood pressure; Endometrial cancer; Kidney cancer; Liver cancer; Pancreatic cancer

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; FINLAND; FOLLOW UP; HEALTH HAZARD; HUMAN; HYPERTENSION; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OBESITY; OUTCOMES RESEARCH; PANCREAS CANCER; POPULATION RESEARCH; PREDICTION; REGRESSION ANALYSIS; STANDARDIZATION; STATISTICAL SIGNIFICANCE;

ADULT; AGED; BLOOD PRESSURE; BODY MASS INDEX; ENDOMETRIAL NEOPLASMS; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; KIDNEY NEOPLASMS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OBESITY; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 18644367036     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001834     Document Type: Article

References (50)

1. Dyer AR et al. High blood-pressure: a risk factor for cancer mortality? Lancet 1975; 1: 1051-1056.
2. Svardsudd K, Tibblin C. Mortality and morbidity during 13.5 years' follow-up in relation to blood pressure. The study of men born in 1913. Acta Med Scand 1979; 205: 483-492.
3. Raynor Jr WJ et al. High blood pressure and 17-year cancer mortality in the Western Electric Health Study. Am J Epidemiol 1981; 113: 371-377.
4. Khaw KT, Barrett-Connor E. Systolic blood pressure and cancer mortality in an elderly population. Am J Epidemiol 1984; 120: 550-558.
5. Goldbourt U et al. Elevated systolic blood pressure as a predictor of long-term cancer mortality: analysis by site and histologic subtype in 10,000 middle-aged and elderly men. J Natl Cancer Inst 1986; 77: 63-70.
6. Filipovsky J et al. Abdominal body mass distribution and elevated blood pressure are associated with increased risk of death from cardiovascular diseases and cancer in middle-aged men. The results of a 15- to 20-year follow-up in the Paris prospective study I. Int J Obes Relat Metab Disord 1993; 17: 197-203.
7. Rosengren A et al. Hypertension and long-term cancer incidence and mortality among Swedish men. J Hypertens 1998; 16: 933-940.
8. Wannamethee G, Shaper AG. Blood pressure and cancer in middle-aged British men. Int J Epidemiol 1996; 25: 22-31.
9. Peeters P et al. Hypertension, antihypertensive drugs, and mortality from cancer among women. J Hypertens 1998; 16: 941-947.
10. Taylor JO et al. Blood pressure and mortality risk in the elderly. Am J Epidemiol 1991; 134: 489-501.
11. Clausen J, Jensen G. Blood pressure and mortality: an epidemiological survey with 10 years follow-up. J Hum Hypertens 1992; 6: 53-59.
12. Grove JS et al. The association of blood pressure with cancer incidence in a prospective study. Am J Epidemiol 1991; 134: 942-947.
13. Batty GD, Shipley MJ, Marmot MG, Davey SG, Whitehall Study. Blood pressure and site-specific cancer mortality: evidence from the original Whitehall study. Br J Cancer 2003; 89: 1243-1247.
14. Shapiro JA et al. Hypertension, antihypertensive medication use, and risk of renal cell carcinoma. Am J Epidemiol 1999; 149: 521-530.
15. Chow WH et al. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 2000; 343: 1305-1311.
16. Parazzini F et al. Population attributable risk for endometrial cancer in northern Italy. Eur J Cancer Clin Oncol 1989; 25: 1451-1456.
17. Soler M et al. Hypertension and hormone-related neoplasms in women. Hypertension 1999; 34: 320-325.
18. Zhang ZF et al. Adenocarcinomas of the esophagus and gastric cardia: medical conditions, tobacco, alcohol, and socioeconomic factors. Cancer Epidemiol Biomarkers Prev 1996; 5: 761-768.
19. Grossman E, Messerli FH, Goldbourt U. Does diuretic therapy increase the risk of renal cell carcinoma? Am J Cardiol 1999; 83: 1090-1093.
20. Lindblad P et al. Risk of kidney cancer among patients using analgesics and diuretics: a population-based cohort study. Int J Cancer 1993; 55: 5-9.
21. Pahor M et al. Do calcium channel blockers increase the risk of cancer? Am J Hypertens 1996; 9: 695-699.
22. Lever AF et al. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 1998; 352: 179-184.
23. Nissinen A, Tuomilehto J, Puska P. The hypertension register of the North Karelia project. Clin Sci Mol Med Suppl 1978; 4: 355s-358s.
24. Puska P et al. The North Karelia Project: 20 Years' Results and Experience. Helsinki, Finland: National Public Health Institute, 1995.
25. Lindgren A, et al. Cancer incidence in hypertensive patients in North Karelia, Finland. Hypertension 2001; 37: 1251-1255.
26. Lindgren A et al. Blood pressure, smoking and the incidence of lung cancer in hypertensive men in North Karelia, Finland. Am J Epidemiol 2003; 158: 442-447.
27. World Health Organization. Arterial Hypertension: Report of a WHO Expert Committee. Geneva, Switzerland: World Health Organization, Technical Report Series 628, 1998.
28. Lindholm LH et al. Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial. Lancet 2001; 358: 539-544.
29. Dyer AR, Elliott P. The INTERSALT study: relations of body mass index to blood pressure. INTERSALT Cooperative Research Group. J Hum Hypertens 1989; 3: 299-308.
30. Jalkanen L et al. Changes in body mass index in a Finnish population between 1972 and 1982. J Int Med 1989; 226: 163-170.
31. Yuan TM et al. Hypertension, obesity and their medications in relation to renal cell carcinoma. Br J Cancer 1998; 77: 1508-1513.
32. McLaughlin JK et al. International renal-cell cancer study. VIII. Role of diuretics, other anti-hypertensive medications and hypertension. Int J Cancer 1995; 63: 216-221.
33. Mellemgaard A et al. Risk factors for renal cell carcinoma in Denmark: role of medication and medical history. Int J Epidemiol 1994; 23: 923-930.
34. Muscat JE, Hoffmann D, Wynder EL. The epidemiology of renal cell carcinoma. A second look. Cancer 1995; 75: 2552-2557.
35. Mellemgaard A, Moller H, Olsen JH. Diuretics may increase risk of renal cell carcinoma. Cancer Causes Control 1992; 3: 309-312.
36. Gago-Dominguez M et al. Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes Control 2002; 13: 287-293.
37. Nissinen A et al. Drug treatment of high blood pressure in the community - experience in eastern Finland. J Hum Hypertens 1989; 3: 165-171.
38. Wallenius S, Peura S, Klaukka T, Enlund H. Who is using antihypertensive drugs? A prescription analysis from Finland. Scand J Prim Health Care 1996; 14: 54-61.
39. Calle EE et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003; 348: 1625-1638.
40. Berrington de Gonzalez A, Sweetland S, Spencer E. A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer 2003; 89: 519-523.
41. Friedman GD, van den Eeden SK. Risk factors for pancreatic cancer: an exploratory study. Int J Epidemiol 1993; 22: 30-37.
42. Stolzenber-Solomon RZ et al. A prospective study of medical conditions, anthropometry, physical activity, and pancreatic cancer in male smokers (Finland). Cancer Causes Control 2002; 13: 417-426.
43. Weiderpass E et al. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 2000; 11: 185-192.
44. Brinton LA et al. Ethnicity and variation in breast cancer incidence. Int J Cancer 1997; 73: 349-355.
45. Inoue M et al. A case-control study on risk factors for uterine endometrial cancer in Japan. Jpn J Cancer Res 1994; 85: 346-350.
46. Parazzini F et al. The epidemiology of endometrial cancer. Gynecol Oncol 1991; 41: 1-16.
47. Furberg AS, Thune I. Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort. Int J Cancer 2003; 104: 669-676.
48. Moller H, Mellemgaard A, Lindvig K, Olsen JH. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 1994; 30A: 344-350.
49. Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM. Obesity and hepatocellular carcinoma. Gastroenterology 2004; 127(5 Suppl 1): S97-S103.
50. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1996; 33: 365-369.